PD-L1 is significantly associated with esophageal cancer progression as it promotes cell viability, proliferation, migration, and metastasis through the decreasing of anti-tumor response to CD8+T that promotes immune system evasion (Brahmer et al., 2012; Chen et al., 2017; Han et al., 2020). The gene discussed is CD274; the disease is neoplasm.